[ad_1] Drug firm Piramal Pharma Ltd on Thursday (March 20) said Piramal Critical Care (PCC) and Ireland-based BrePco Biopharma Ltd (BPCO) have received UK Medicines and Healthcare Products Regulatory Agency (MHRA) approval for Naeoatricon, the first paediatric-strength dopamine hydrochloride infusion for treating hypotension in neonates, infants, and children. Piramal Critical Care has secured commercialisation rights […]
Piramal Pharma’s Mumbai facility gets 6 observations from US FDA inspection – CNBC TV18
[ad_1] Pharmaceutical firm Piramal Pharma Ltd on Tuesday (February 18) announced that the US FDA conducted a general GMP (Good Manufacturing Practice) inspection at its Turbhe, Navi Mumbai, facility between February 11-17, 2025. The inspection concluded with a Form 483 issued, containing six observations. Company Value Change %Change “This is to inform you that the […]
Piramal Pharma Q3 Results | Net profit tanks 63% to ₹4 crore, revenue climbs 13% to ₹2,204 crore – CNBC TV18
[ad_1] Piramal Pharma Ltd on Tuesday (January 28) reported a 63.4% year-on-year (YoY) decline in net profit at ₹3.7 crore for the third quarter that ended December 31, 2024. Company Value Change %Change In the corresponding quarter of the previous fiscal, Piramal Pharma posted a net profit of ₹10.1 crore, the company said in a regulatory filing. The […]
Piramal Pharma’s critical care division launches Chlorpromazine injection in US – CNBC TV18
[ad_1] Piramal Pharma Ltd on Wednesday (January 22) said its division Piramal Critical Care (PCC) has announced the US launch of Chlorpromazine Hydrochloride for Injection, USP. The product will be available in two vial formats—25 mg/1 mL and 50 mg/2 mL—marking an expansion of PCC’s generic injectables portfolio. Company Value Change %Change The launch of […]